DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹487 Cr | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹487 Cr |
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹292 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹487 Cr | 36.17 | |
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | - | |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹32,067.4 Cr | 0.9% | 1% | 17.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,792.0 Cr | 2% | 2.6% | 13.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹103,069.0 Cr | 2.6% | 6.2% | -8.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹67,512.1 Cr | 3% | -1% | -7.3% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹65,493.1 Cr | 1.4% | -1.3% | 22.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,480.1 Cr | 1.7% | 3.7% | 6.2% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 0.9% |
1% |
17.1% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses